Rad AI is a healthcare-focused company that is striving to develop generative AI solutions for radiologists. Rad AI was founded in 2018 and is headquartered in San Francisco, CA. The company is aiming to use AI to assist radiologists so they are less likely to experience burnout while striving to improve the quality of care they provide to patients, including diagnosis of cancer and other conditions.
Rad AI is privately held and not traded on public markets, so pre-IPO investments are available only to accredited investors.
If you’re already accredited and have completed Forge’s verification, you can visit our marketplace to review and invest in private companies ahead of an IPO.
If you haven’t yet completed your accredited investor verification with Forge, you can start that process now to unlock access to new private-company offerings.
Can you sell shares of Rad AI before it goes public?
Yes, subject to any contractual or corporate transfer restrictions, it is possible to list your shares to sell while Rad AI is still private. If you’re considering selling, you can register today for free to get started. Once registered, you can evaluate pricing insights and market activity to inform your decision, then post your shares for sale and set the terms, like quantity and price—all directly through our platform.
If you’d like additional guidance at any point, Forge private market specialists are available to help. For a step-by-step overview, check out our seller’s guide.
What is the pre-IPO value of my Rad AI shares?
To explore the value of your Rad AI shares, create a free account to access Forge’s marketplace. Once inside, you’ll find several pricing insights to help guide your decision—these include historical transaction data, a live order book showing current buy and sell interest, and Forge Price™, a derived, indicative price based on recent transactions, investor activity, and other relevant market data.
These insights can help you determine a price you’re comfortable with if you choose to sell your shares. If you’d like additional guidance along the way, Forge private market specialists are available to help. You can also review our seller’s guide for a step-by-step overview.
Is Rad AI a publicly traded company?
Rad AI is a private company and not publicly traded.
If you’re interested in buying or selling shares in private companies, you can register with Forge today for free to explore available opportunities. Once registered, you’ll gain access to our marketplace, where you can view active buy and sell interest, evaluate pricing signals and take action directly through the platform.
To learn more about Rad AI potential IPO
Will Rad AI go IPO?
Rad AI has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2025.
What is Rad AI’s IPO price?
The Rad AI IPO price does not exist at this time, as Rad AI is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Rad AI, register for Forge today.
When was Rad AI founded?
Rad AI was founded in 2018.
What is Rad AI funding to date?
Rad AI has raised $163.36MM to date.
Rad AI major investors
Alpha Partners
Array Ventures
Artis Ventures
City Light Capital
Fifty Years
Gannett Partners
Gmo Venture Partners
Gradient Ventures
Harmonix Fund
Hike Ventures
Hyperlink Ventures
Impactassets
Khosla Ventures
Kickstart Fund
Ocv Partners
Precursor Ventures
Proof
Renn Ventures
Santa Barbara Venture Partners
Up2398
Wil (World Innovation Lab)
Show All InvestorsShow Fewer Investors
Rad AI pre-IPO valuation and funding rounds
Funding history chart
Funding round and deals details
Funding Date
Round
Amount Raised
Price per Share
Post-Money Valuation 3
Key Investors
05/20/2025
Series C
$80.9MM
$22.51
$527.53MM
Advocate Health, Atlantic Health System, Cone Health Ventures, Corewell Health, Khosla Ventures, Kickstart, Memorial Hermann Health System, Ocv Partners, Transformation Capital, Up2398, World Innovation Lab
Price per Share
$ xx.xx
Shares Outstanding
3,593,591
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Advocate Health, Atlantic Health System, Cone Health Ventures, Corewell Health, Khosla Ventures, Kickstart, Memorial Hermann Health System, Ocv Partners, Transformation Capital, Up2398, World Innovation Lab
05/07/2024
Series B-1
$33.56MM
$13.99
$276.13MM
Artis Ventures, Gradient Ventures, Hyperlink Ventures, Khosla Ventures, Kickstart, Ocv Partners, World Innovation Lab
Price per Share
$ xx.xx
Shares Outstanding
2,399,034
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Artis Ventures, Gradient Ventures, Hyperlink Ventures, Khosla Ventures, Kickstart, Ocv Partners, World Innovation Lab
05/07/2024
Series B-2
$16.44MM
$9.22
$276.13MM
Artis Ventures, Gradient Ventures, Hyperlink Ventures, Khosla Ventures, Kickstart, Ocv Partners, World Innovation Lab
Price per Share
$ xx.xx
Shares Outstanding
1,783,542
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Artis Ventures, Gradient Ventures, Hyperlink Ventures, Khosla Ventures, Kickstart, Ocv Partners, World Innovation Lab
11/10/2021
Series A-1
$20.25MM
$5.77
$93.24MM
Artis Ventures, City Light Capital, Gradient Ventures, Kickstart, Ocv Partners, Proof, Renn Ventures, Santa Barbara Venture Partners
Price per Share
$ xx.xx
Shares Outstanding
3,510,591
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Artis Ventures, City Light Capital, Gradient Ventures, Kickstart, Ocv Partners, Proof, Renn Ventures, Santa Barbara Venture Partners
11/10/2021
Series A-2
$1.18MM
$4.90
$93.24MM
Artis Ventures, City Light Capital, Gradient Ventures, Kickstart, Ocv Partners, Proof, Renn Ventures, Santa Barbara Venture Partners
Price per Share
$ xx.xx
Shares Outstanding
241,701
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Artis Ventures, City Light Capital, Gradient Ventures, Kickstart, Ocv Partners, Proof, Renn Ventures, Santa Barbara Venture Partners
11/10/2021
Series A-3
$4.01MM
$3.03
$93.24MM
Artis Ventures, City Light Capital, Gradient Ventures, Kickstart, Ocv Partners, Proof, Renn Ventures, Santa Barbara Venture Partners
Price per Share
$ xx.xx
Shares Outstanding
1,324,132
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Artis Ventures, City Light Capital, Gradient Ventures, Kickstart, Ocv Partners, Proof, Renn Ventures, Santa Barbara Venture Partners
08/20/2020
Series Seed-1
$3.88MM
$3.30
$31.38MM
Undisclosed Investors
Price per Share
$ xx.xx
Shares Outstanding
1,177,644
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
11/25/2019
Series Seed-2
$3MM
$2.68
$21.38MM
Array Ventures, City Light Capital, Fifty Years Vc, Gmo Venture Partners, Gradient Ventures, Harmonix, Hike Ventures, Kickstart, Precursor Ventures, Up2398
Price per Share
$ xx.xx
Shares Outstanding
1,117,524
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Array Ventures, City Light Capital, Fifty Years Vc, Gmo Venture Partners, Gradient Ventures, Harmonix, Hike Ventures, Kickstart, Precursor Ventures, Up2398
11/25/2019
Series Seed-3
$74,976.41
$2.24
$21.38MM
Array Ventures, City Light Capital, Fifty Years Vc, Gmo Venture Partners, Gradient Ventures, Harmonix, Hike Ventures, Kickstart, Precursor Ventures, Up2398
Price per Share
$ xx.xx
Shares Outstanding
33,515
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Array Ventures, City Light Capital, Fifty Years Vc, Gmo Venture Partners, Gradient Ventures, Harmonix, Hike Ventures, Kickstart, Precursor Ventures, Up2398
11/25/2019
Series Seed-4
$49,996.65
$1.34
$21.38MM
Array Ventures, City Light Capital, Fifty Years Vc, Gmo Venture Partners, Gradient Ventures, Harmonix, Hike Ventures, Kickstart, Precursor Ventures, Up2398
Price per Share
$ xx.xx
Shares Outstanding
37,247
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Array Ventures, City Light Capital, Fifty Years Vc, Gmo Venture Partners, Gradient Ventures, Harmonix, Hike Ventures, Kickstart, Precursor Ventures, Up2398
11/25/2019
Series Seed-5
$171.31
$0.01
$21.38MM
Array Ventures, City Light Capital, Fifty Years Vc, Gmo Venture Partners, Gradient Ventures, Harmonix, Hike Ventures, Kickstart, Precursor Ventures, Up2398
Price per Share
$ xx.xx
Shares Outstanding
17,131
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Array Ventures, City Light Capital, Fifty Years Vc, Gmo Venture Partners, Gradient Ventures, Harmonix, Hike Ventures, Kickstart, Precursor Ventures, Up2398
Wake Radiology UNC REX Healthcare, a leading provider of outpatient medical imaging in the Triangle, is proud to announce its partnership with Rad AI to implement its radiology reporting software: Rad AI Reporting. This software is set to revolutionize the field by enhancing reporting accuracy and efficiency. By utilizing generative AI and advanced machine learning algorithms, the award-winning Rad AI Reporting enables a “Speak Less, Say More” experience.
Rad AI, a leader in generative AI for healthcare, today announced it raised $50 million in Series B financing. The round was led by Khosla Ventures, with participation from WiL (World Innovation Lab) and existing investors ARTIS Ventures, OCV Partners, Kickstart Fund, and Gradient Ventures (Google's AI-focused fund), among others, bringing total capital raised to over $80 million. Rad AI's solutions are already used by more than a third of all US health systems and by 9 of the 10 largest US radiology practices, saving physicians hours each day and helping ensure patients' new cancers are diagnosed and treated promptly.
On Tuesday, Khosla led a $50 million Series B into Rad AI, which developed a tool that can generate reports for radiologists. Other participants in the round included World Innovation Lab and returning investors ARTIS Ventures, OCV Partners, Kickstart Fund and Gradient Ventures (Google’s AI-focused fund). The financing brought the company’s total capital raised to over $80 million. Rad AI was founded in 2018 by Dr. Jeff Chang, who completed his medical training as a radiologist when he was 16 and later received an MBA from UCLA, and serial entrepreneur Doktor Gurson.
Rad AI, a startup that developed an AI platform for radiology, is teaming up with Google to use its cloud and large language models to streamline workflows and reduce radiologists' administrative burdens. Founder Dr. Jeff Chang, a radiologist, started the company because he was troubled by high error rates, radiologist burnout and rising imaging demand despite a worsening shortage of U.S. radiologists. Rad AI uses state-of-the-art machine learning and AI to automate repetitive tasks for radiologists and automate workflow for health systems.
Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.
Forge, your trusted partner for pre-IPO insights and Rad AI data
Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.
‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.
The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.
Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.
PRIVATE MARKET UPDATE
